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PROJECT EXECUTION 
 
FOOD-CT-2006-36353 
 
goatBSE 
 
Proposal for improvement of goat TSE discriminative diagnosis 
and susceptibility based assessment 
of BSE infectivity in goat milk and meat. 
 
 
www.goatBSE.eu 
 
Project Objectives 
In light of the known ability of the BSE agent to cross the animal/human species barrier, 
the evidence establishing the presence of BSE in goat is especially alarming, as it 
represents a potential risk of food-born contamination to human consumers of goat milk 
and meat products. The main objective has been to determine the tissue distribution of 
BSE after oral exposure of goats while simultaneously generating indispensable data on 
genetic susceptibility in the most commonly used production breeds. This proposal aims:  
(i) at providing data to allow evaluation of human risk associated with BSE passaged in 
goat,  
(ii) at providing pathogenesis data and biological material from first and second passage 
BSE in goats,  
(iii) at evaluating the possibility of BSE self-maintenance in goats by maternal/horizontal 
transmission, 
(iv) at validating and improving our ability to detect and discriminate caprine BSE from 
goat scrapie. 
Our approach integrates the predicted influence of PrP gene polymorphisms on scrapie 
and BSE susceptibility so that it could potentially be used for the control of field TSE 
outbreaks in goats. We will document European field TSE strain variability in goats by 
recruiting a large number of TSE goat isolates from affected European countries. Already 
established or specifically created animals models (strain typing) and biochemical tools 
(PrPSc typing) are being investigated for their ability to efficiently discriminate BSE from 
scrapie in goats. Finally, by measuring infectivity in various tissues (including skeletal 
muscle) and secretions (milk), collected from goats at different stages of BSE infection, 
we will provide indispensable data for quantitative risk assessment.  
 
The intended work contains five work packages which setting is shown in the pert 
diagram on the next page. Then, after discussing a number of scientific end results (page 
7-14), the level of fullfillment of these main four project objectives will be presented on 
pages 15-18. 
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Figure: Pert diagram to show the exchanges and interactions between the individual Work packages of 
the project. Collaborations were started in 2009 year 3 with: T. Baron ANSES Lyon France, J. Spiropoulos 
DEFRA AHVLA-Weybridge New Haw United Kingdom, & P. Stylianou Veterinary Services Nicosia Cyprus. 
CONTRACTORS INVOLVED 
This consortium consists of 10 partners from 7 EU Member states; 
Partner 1: Central Veterinary Institute of Wageningen UR (former CIDC-Lelystad), Lelystad, 
The Netherlands (jan.langeveld@wur.nl). Coordinator, WP5 leader. 
Partner 2:  Institut National de la recherché Agronomique (INRA), France 
P2.a: UMR INRA/ENVT 1225 Interactions Hôtes Agents Pathogènes, Toulouse. WP2 leader 
P2.b: INRA-Tours, UR 918 - Laboratoire de Pathologie Infectieuse et Immunologie (PII), 
Research Centre of Tours-Nouzilly 
P2.c: INRA SAGA-LGBC, Toulouse 
Partner 12:Roslin Institute & R(D)SVS, University of Edinburgh, Edinburgh, UK. WP1 leader. 
Partner 4: INIA, Madrid, Spain. WP4 leader. 
Partner 5: UNIZAR, Zaragoza, Spain. 
Partner 6: FLI-INEID, Riems, Germany. 
Partner 7: IZSPLV, Turin, Italy. 
Partner 8: ISS, Rome, Italy. WP3 leader. 
Partner 9: CERTH-INA, Thessaloniki, Greece 
Partner 10:CEA, Saclay, France. 
 
Coordinator contact details 
J. Langeveld secretary / A. Bossers coordinator 
Central Veterinary Institute of Wageningen UR (former CIDC-Lelystad) 
PO box 65, NL-8200 AB Lelystad, The Netherlands 
email: jan.langeveld@wur.nl 
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Who are we? 
 
 
1 Peter Moonen (P1 CVI NL, has left), 2 Theodoros (P9 CERTH-INA GR), 3 Alex Bossers (P1 CVI NL), 4 
Simone Peletto (P7 IZSTO IT), 5 Eva Monléon (P5 UNIZAR SP), 6 Jacques Grassi (P10 CEA FR),  7 Marti 
Eiden (P6 FLI GE), 8 Romolo Nonno (P8 ISS IT), 9 Herve Cassard (P2b INRA-Tours FR, has left), 10 
Martin Groschup (P6 FLI GE), 11 Umberto Agrimi (P8 ISS IT), 12 Cindy Panagiotidis (P9 CERTH-INA GR), 
13 Cristina Acin (P5 UNIZAR SP), 14 Kelly Ryan (P12 UEDIN-Roslin UK), 15 Wilfred Goldmann (P12 
UEDIN-Roslin UK), 16 Patricia Berthon (P2b INRA-Tours FR), 17 Isabelle Lantier (P2b INRA-Tours FR), 18 
Frederic Lantier (P2b INRA Tours FR), 19 Juan Maria Torres (P4 INIA SP), 20 Olivier Andreoletti (P2a 
INRA-ENVT Toulouse FR), 21 Francis Barillet (P2c INRA-SAGA Toulouse FR), 22 Hugue Caillat (P2a INRA-
ENVT Toulouse FR), 23 Jan Langeveld (P1 CVI NL), 24 Gabriele Vaccari (P8 ISS IT), 25 Penelope 
Stylianou (visiting member Veterinary Services Cyprus), 26 Nathalie Kasal (P2a INRA-ENVT FR, has left), 
27 Pavlos Toumazos (visiting member Veterinary Services Cyprus, retired). Contributors not on picture: 
John Spiropoulos (associate member AHVLA Weybridge UK),  Thierry Baron (ANSES Lyon FR). 
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END RESULTS 
Projects: GoatBSE and GOAT-TSE on the internet: 
 
www.goatbse.eu 
 
 
logo of the GoatBSE project (FP6) 
 
 
logo of the GOAT-TSE-FREE project (EMIDA ERA-NET) 
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View on some results combined from different 
work packages 
 
Finding TSE-protective prion protein (PrP) alleles in goats 
Data from field studies in different countries and laboratories (Italy, 
Greece, France) pointed out that the 222K PrP allele is a serious candidate 
for TSE resistance breeding. Data from challenge studies with scrapie 
(intracerebral) and BSE (1st and 2nd oral passage) confirm this choice, 
though some carriers show sub- or pre-clinical signs of disease at the end 
of the experiment (>1900 days post infection), while goats with the wild 
type, 142I/M or 211R/Q genotype nearly all went much earlier down with 
disease. Bioassay studies in newly generated mice transgenic for wild 
type, 142M or 222K goat-PrP challenged with goat scrapie, bovine BSE 
and goat BSE showed resistance in the 222K mice for bovine BSE and 
goat scrapie; however in these mice, the resistance for BSE was not 
absolute since goat-derived BSE (obtained by experimental infection with 
bovine BSE in goats) appeared well transmissible. Similarly, in vitro 
assays using PrPC from either prokaryotic or eukaryotic origin as substrate 
indicated that goat scrapie and bovine BSE were very poor converters of 
normal PrPC to the disease associated form PrPSc, while goat BSE was an 
efficient converting agent. In short, the PrP 222K allele is a powerful 
protective allele for scrapie and BSE, though not absolute. This imperfect 
situation however is also known for sheep 171R allele carriers (ARR 
sheep). This allele is a highly successful target in sheep TSE-resistance 
breeding programs (see Figure 1). 
 
Figure 1: The outcomes of a large part of two work packages summarized in four items has 
revealed that the 222K PrP allele is an outstanding candidate for TSE-resistance breeding initiatives 
in goats. Abbreviations i.c. = intracerebrally challenged with agent indicated. The 154H allele was 
only partially tested i.e. under panels 1and  4. 
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In seven EU countries the GoatBSE consortium has searched widely in the 
goat population for the variability of the PRNP gene. This gene is coding 
for the PrP protein. This was carried out for two reasons:  
1. estimating the genetic variation within the protein, and concomitant 
estimating the frequencies of the most interesting resistance 
associated variants coding for PrP with either 142M, 146S, 146D, 
154H, 221Q or 222K, 
2. finding a relation between disease and DNA sequence variation 
within the regulatory (or promotor) region of PRNP. 
 
PrP-gene analysis: frequencies of most interesting alleles related 
to TSE protection 
With respect to genetic variation, a review7 was published in 2009 that 
reported the number of coding variants at 29, however since then and 
largely due to the consortium efforts this number has increased to over 40 
based on more than 6000 analyses (these variants were G61S, G74D, 
G96D, G97D, S106R, M112T, V125I, L141F, D147N, Y153S, Q215R, 
Q220L). The frequencies of the most important alleles related to potential 
TSE resistance are displayed in figure 2, together with their occurrence in 
the seven countries involved. The 171R allele used for sheep TSE 
resistance breeding has not been encountered in goats. The 222K variant 
is occurring at low frequencies of 0.5-15%, and is absent in some breeds. 
 
Figure 2: Allele frequencies for PrP codons wt, 142M, 146S, 146D, 154H, 211Q & 222K: overall 
averages per country. The codon 240 polymorphism in goats is different from that in sheep: in 
sheep the codon is a serine (S) while in goats this can be a proline (P) or a serine (S) with a 
majority for P in most breeds. Therefore, for each specific allele at other codons than 240, the 240 
polymorphism is specified. The bars above “rest alleles” do reflect the remainder of polymorphisms 
together, which can be associated with either 240P or 240S. 
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Goat breeds investigated for the amino acid sequence of prion protein 
(PrP) and frequency of occurrence of scrapie-resistance associated  
variations. 
 
   
Alpine Saanen Corsica Skopelos Damascus 
(Gr, Fr, NL, Sp) (Fr, It, Nl, Sp) (Fr) (Gr) (Cyp) 
 
     
Valdostana  Roccaverano Camosciata delle Alpi Rossa Mediterranea Maltese 
(It) (It) (It) (It) (It) 
 
          
 Garganica Murciano    Retinta  Pyrenaica Poitevine 
 (It) Granadina (Sp)   (Sp)  (Sp) (Fr) 
 
   
  
Moncaina (Sp) Boerbok (SA, UK, NL) 
 
 
PrP-gene analysis: regulation 
Analytical results from studies of the PRNP gene regulatory region 
compared with those in other reports on the non-coding regions in goats 
and other species allowed the identification of putative transcription factor 
binding motifs. The preliminary results suggest that at least two 
transcription factors bind to sequence motifs in the caprine PRNP gene 
intron I between position 5840 and 5865. Binding of these factors could 
represent a novel regulatory mechanism for PRNP gene expression in 
tissue. Further work is required to prove this possible link. 
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TSE agent  variations in European countries 
Scrapie in small ruminants does 
exist already for a long time. The 
nature of the agent in goats was 
however not well studied. Initially 
the project considered more than 
sixty cases over a large 
geographical area of Europe, and 
ultimately selected twenty four of 
them (see Figure 3) for in-depth 
analyses by means of biochemical, 
microscopic and rodent bioassays. 
Some bioassays are still running. 
Parallel to these assays, a goat 
BSE brain sample was tested; this 
was derived from a goat 
experimentally infected with 
bovine BSE.  
 
 
 
 
Figure 3: Origin of the twenty four cases from seven countries in Europe analysed in the GoatBSE 
project that were included as much as possible in all studies. The cases from UK and NL were 
derived from one single herd, the others all represented cases from different herds. Over thirty 
cases have been analysed in at least one rodent line. 
 
Four main aspects have been investigated on these sample sets 
(Figure 4). None of the field cases yielded a BSE suspicion. Studies by 
microscopy, biochemistry and bioassays have been performed. For the 
latter two studies brain stem materials were first centrally collected, 
homogenized to 50% in water and then finally distributed to partner 
laboratories. For microscopy, fixed tissue blocks were available.  
1. Rapid testing. Three rapid EU tests approved for active surveillance 
performed with 100% specificity on a set of negative samples, while 
sensitivity for the positive sample set ranged between were 
respectively 76%,  and 95%. 
2. By microscopy, all TSE isolates behaved as classical scrapie, except 
one case from UK which in the brain was like CH1641, using suitable 
site-specific antibodies. From Italy an atypical/Nor98 case was 
recognized. 
3. New biochemical techniques were developed to identify the PrPSc type. 
These techniques used the protease susceptibility of PrPSc in two 
approaches: A, removal of the N-terminal side of PrPSc protein,  B, 
degradation of the whole PrPSc molecule.  
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Figure 4: Approaches to evaluate the TSE nature in set of geographically collected isolates: 
approaches were rapid test performance, confirmatory microscopy, confirmatory 
biochemical tests and bioassay strain typing.  
 
Approach A was able to discriminate between classical scrapie from 
Italy (5 cases from Italy, 1 case from France), 1 case of CH1641-like 
scrapie (from UK), and classical scrapie as usual with relatively high 
resistance to protease digestion (remaining 17 field cases), while the 
parallel BSE sample was most susceptible. 
In approach B however, BSE behaves as the most protease resistant 
PrPSc, while the other isolates were variable in their resistance, but this 
could not be related to any origin or typing parameter. 
By further available biochemical parameters the TSE status of most 
samples could also be confirmed for the protease resistant moiety of 
PrPSc (PrPres) prepared under standard protocols. PrPres parameters 
were: molecular weight of lower band, glycoprofile, antibody binding, 
and indications for a dual population as in CH1641 scrapie (only UK 
case). BSE was excluded in any of them. One case of 
atypical/Nor98-like scrapie (from Italy) and one of CH1641-like scrapie 
(from UK) were discovered. The remainder behaved like classical 
scrapie. 
4. By bioassay rodent lines: Atypical scrapie (only transmissible in Tg338 
ovPrPVRQ mice) and experimental BSE (typically transmissible in all 
lines, with stable features) could be recognized in each line with 
consistent features as expected for these two TSE types. Regarding the 
remaining field goat isolates in the geographical study, none of the 
strains isolated in rodents was similar to BSE and in all rodent models 
there was evidence of strain variability. Italian classical scrapie cases 
and one French case were detected as a homogeneous type of scrapie 
in different rodent models (provisionally named: Italian scrapie). The 
other isolates (from Greece, Cyprus, Spain, Netherlands, France and 
UK) gave a divergent picture, interpreted as presence of different 
“sub-strain” components in some sample: i.e. in conventional mice and 
bank voles, these isolates resulted in classical scrapie strains previously 
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identified in sheep, including CH1641-like scrapie. One UK goat case 
with CH1641-like molecular properties - as mentioned above under 
point 3 approach B - was a clear example of a phenotype from which 
both CH1641 and classical scrapie could be isolated.  
 
Distribution of agent in goat lymphoid, nervous system and muscle 
tissues upon oral infection 
A large set of goats have been subjected to challenge through the oral 
route with either bovine BSE or goat BSE. In some of these goats, 
spreading of disease in the body was more closely followed until the end 
of the experiments (about 45 months post challenge). This was 
accomplished by two ways: by microscopy with PrP-specific antibodies, 
and by infectivity in the most susceptible mouse line (Tg110 mice, 
transgenic for bovine PrP). 
By microscopy, all genotypes tested except 222Q/K were clearly positive 
in the brain in both 1st and 2nd passage, with nerve cells of the enteric 
system (ENS) also positive but the lymph nodes were usually negative or 
sparsely positive (Table 1). 
 
Table 1: goats challenged with BSE from cattle or goat through the mouth exhibit positivity in their 
gut nerves when positive in the brain. Brain positive goats were also positive by visibly clinical 
signs. The involvement of lymph nodes was very limited and not always present though locally the 
ENS was positive. The 142M/M goats remained negative after 2nd oral passage like nearly all 
222Q/K goats in both passages. Y=positive, N=negative, ± = a slight positivity only in some 
case(s) per group. 
 
By infection in mice, samples collected from goats in end stage of disease 
or at end of the experiment showed that tissues tested (brain, muscle and 
popliteal lymph nodes) were positive in wt and 211R/Q genotype animals, 
and that both muscle and lymph node are carrying infectivity at a level 
100 – 1000 times lower that in brain, which means that still a rather high 
infectivity level can be present in the body. The muscles tested were from 
the eye and thigh bone muscle, lymph nodes were from the knee joint. 
Thus infectivity will spread to the periphery at late stage of the infection 
process, and the 222Q/K genotype carrying goats are only at non-clinical 
stage at about 4 years after challenge positive in only the brain. 
Apparently, after oral infection infectivity moves from gut through body 
nerve cells to brain after which it can spread to muscle and lymph nodes. 
To find arguments whether or not these tissues are infective to humans, 
infection studies in transgenic mice expressing human PrP are on-going. 
CNS (brain) ENS (gut 
nerves)
LRS (lymph 
nodes)
CNS (brain) ENS (gut 
nerves)
LRS (lymph 
nodes)
wt Y Y ± Y Y ±
142I/M Y Y ± Y Y ±
142M/M Y Y ± N N N
211R/Q Y Y ± Y Y ±
222Q/K ± N N N N N
1st oral passage 2nd oral passage
geno 
type
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Production of goat milk and delivery of goat kids and infectivity 
testing 
Oral challenge of goats with goat BSE leads to appreciable levels of 
infectivity in consumption related tissues of wild type and 211R/Q goats, 
while 222Q/K goats are protected to a high level. Experiments are still on-
going. It is not yet clear whether there is infectivity present in milk 
products derived from these goats (for a summarizing plan of these 
experiments see Figure 5). 
With respect to placenta and the kids derived from infected wild type 
goats: timing of mating and challenge periods were well chosen since 
dams became clinically positive in the susceptible genotypes around 
weaning. By microscopy, goat kids and placentas were negative, and by 
infectivity tests (only placenta tested in Tg-shpIX mice). The limited 
number of animals involved in the experiments does not allow to definitely 
conclude that vertical transmission does not occur. 
 
Figure 5: Overview of research activities in Work package 4 to obtain data on risks of goat adapted 
BSE to human consumers. 
Susceptibility of different species for goat BSE and scrapie 
For BSE transmission to other species there was hardly any barrier in the 
studied rodent models and goat derived BSE even showed an increased 
transmissibility in Tg-Bov, Tg-Po and Tg-Hu mice compared to cattle BSE. 
In the same study, scrapie did not transmit in the presence of human 
(129M) or porcine PrP. These results suggest that the risk in humans for a 
potential goat-BSE agent should not be underestimated. 
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Degree objectives reached 
As appeared from the above paragraphs, the objectives stated at the 
beginning of this report on page five have been reached in many ways by 
performing the different work packages.  
 
The work will be detailed in relation to the main aims posed in the 
proposal DOW v41 which were: 
1. providing data to allow evaluation of human risk associated with BSE 
passaged in goat,  
2. providing pathogenesis data and biological material from first and 
second passage BSE in goats,  
3. evaluating the possibility of BSE self-maintenance in goats by 
maternal/horizontal transmission, 
4. validating and improving our ability to detect and discriminate caprine 
BSE from goat scrapie. 
 
The degree of objectives reached is summarized at the end of this 
paragraph in Table 2. 
1 Providing data to allow evaluation of human risk associated with 
BSE passaged in goat 
In work packages WP1, WP2 and WP4, data have been generated to 
evaluate factors that can be used for human risk assessment if an 
eventual event of BSE in goat would occur. These data were generated 
by: raising goats of different prion protein (PrP) polymorphisms or genetic 
genotypes using pre-existing knowledge about field studies where a 
resistance association was found for a number of alleles. In the first two 
years of the project challenges in these animals could be started. In work 
package 1 transgenic mice were generated containing different goat PrP 
variants. Humanized mice were stationed at two consortium member 
institutions. For in vitro test-development PrPs were produced for a set of 
goat variants and the human 129V and 129M variants, and conditions for 
new types of conversions have been developed, including conversion 
substrates production being non-glycosylated PrPs from pro-karyotic cells 
and glycosylated PrPs from mammalian cells. Some of the goats were 
used for breeding goat kids to establish any indication of presence of 
infectivity in the milk and tissues generated for studies in this objective. 
Important conclusions could be drawn from the experiments, while testing 
of milk fractions is still underway (in humanized and bovinized mice).  
The main achieved conclusions are:  
 Transmission experiments in transgenic mice expressing goat-PrP 
showed that, as expected, all goat BSE isolates, in contrast to scrapie 
isolates tested, are well transmitted, without apparent transmission 
barrier. Thus, also humanized 129M Tg mice are susceptible for goat 
BSE. Testing of infectivity in goat mother milk samples is still on-going 
in humanized transgenic mice (expected to be ready around 
2013/2014).  
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 In all transmitting goat BSE samples, the molecular signature of the 
PrPres generated in the mice was similar to that observed in the original 
inoculum.  
 The in vitro tests assessing conversion efficiency associated with 
various caprine PrP sequences reflect the in vivo susceptibility of 
transgenic mice and goats (as studied in the deliverables D1 and D2 
series). Goat-passaged BSE is well capable to convert all goat PrPs 
relatively efficiently except for the ovine 171R PrP allelic variant which 
only showed a very limited conversion, while conversion of the human 
PrP allelic variants 129M and 129V have to be repeated for a definite 
interpretation which is pending. 
 The results suggest that the risk in humans for a potential goat-BSE 
agent should not be underestimated. 
2 Providing pathogenesis data and biological material from first 
and second passage BSE in goats 
In work packages WP2 and WP4, information has been generated about 
the spread of infectivity in goats challenged with BSE at first and second 
passage, either after intracerebral or oral administration. Goats from 
different genotypes (wt, 142I/M, 142M/M, 211R/Q and 222Q/K (only oral 
administrations) have been challenged. A broad set of tissues were 
collected such as: brain, spinal cord, extra-neuronal nerves,  lymph nodes 
from head and gut, lymph nodes including intestinal samples, spleen, and 
muscles. These are available for further investigations from the partner’s 
laboratories in case of interest. Most interesting was that oral infection of 
goats with goatBSE leads to appreciable levels of infectivity in 
consumption related tissues (muscles), while it is not yet clear whether in 
milk products derived from these goats there is infectivity present. 
Infectivity tests on the goat tissues in the Tg mouse bioassays are still 
ongoing. It also appeared from the mouse studies, that infectivity will 
spread to the periphery at late stage of the infection process in all 
diseased wt, 142I/M, and 211R/Q goats; only one 222Q/K genotype 
carrying goat was positive only in the brain in still healthy (non-clinical) 
stage at 4 years after challenge. Thus, a relatively strong protection to 
BSE infection exists in 222Q/K goats. Furthermore apparently after oral 
intake, BSE infectivity moves from gut through body nerve cells to brain 
after which it can spread to muscle and lymph nodes. 
With respect to goat scrapie: goats (genotypes: wt, 142I/M, 154R/H, 
211R/Q, 211Q/Q, 222Q/K, 222K/K) were investigated after intracerebral 
challenge and all genotypes became positive, but none of the 222K allele 
carriers except one out of five 211Q/K animals; lymph node positivity (by 
microscopy) did appear only in the wt, 211R/Q, and 142I/M animals. 
Thus, only the 222K polymorphism carriers demonstrate strong resistance 
to intracerebral scrapie infection, though in heterozygous condition the 
resistance was not complete. 
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3 Evaluating the possibility of BSE self-maintenance in goats by 
maternal/horizontal transmission.  
Work packages WP2 and WP4 used two different approaches to study 
potential transmission of BSE horizontally and maternally (vertically). 
With respect to horizontal transmission, during the oral and intracerebral 
BSE challenges  -either 1st or 2nd passage- always one or two goats were 
present in the same pen as a kind of sentinel animals. In none of the 
experiments these animals turned out to be TSE positive by microscopy or 
clinical signs up till 48 months post challenge of the experimental 
infections. Another horizontal route of infection could have been the 
drinking from mother goats by other goats, including by the kids. This 
route was not possible to investigate. In most cases placenta was 
removed from the delivering mothers at birth; it must be mentioned here 
that the placentas investigated appeared negative by IHC microscopy. 
With respect to maternal/vertical transmission, goat kids from wild type 
PrP mothers have been drinking during the most susceptible period since 
there was clinical positivity within 1-2 months after delivery with respect 
to a wild type mother goat; mother goats with PrP genotype 211R/Q and 
222Q/K were probably too early mated to have a heavy spread of disease 
at the time kids were drinking from them. 
The kids from 1st passage BSE infected mothers have been euthanized 
early (5-7 months old). Detecting signs of infection by drinking should not 
be expected in these cases, and all kids were negative at euthanasia by 
IHC microscopy and biochemistry for PrPSc.  
All the kids from the 2nd passage BSE infected mother goats remained 
negative by tonsil biopsy and none have shown any signs at time of 
euthanasia (27 months old). Nevertheless, the limited number of animals 
involved in the experiments does not allow to definitely conclude that 
vertical transmission does not occur. 
Milk samples of the mothers during early lactation are under investigation 
still in both ovinized (TgshpIX, ovPrPARQ; not planned in the DOW v41) and 
bovinized (Tg110, boPrP, as planned in WP4) transgenic mice. Here part 
of the milk at early and late lactation were fractionated into cells, whey 
serum and immunoprecipitated prion material from whey and cream. 
These infectivity studies are underway at about 400-600 days (per 
January 2013) and will be finished in 2013. 
 
4 Validating and improving our ability to detect and discriminate 
caprine BSE from goat scrapie  
Activities from WP3 together with WP1 and WP2. 
To know the use of diagnostic tools for goat TSEs means to know the way 
to differentiate strains and isolate types, and also BSE if it were present. 
That it can be present is clear from the detection of two cases of BSE in 
goats, one in France and one in United Kingdom9. This project has carried 
out a unique activity to reach this aim.  
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A wide geographical collection of >60 goat scrapie/TSE isolates was made 
available to: 
1. check three current EU approved tests for rapid testing in the active 
surveillance,  
2. find specific tools for TSE analysis in goats, 
3. use and improve discriminatory confirmation diagnostics that are 
currently used for small ruminants but which have been mainly 
developed using goat TSE materials, 
4. to analyze the isolates in rodent models for their strain type properties. 
To perform all these 4 tasks a selection from this collection was made to 
have as much variability factors involved as possible: thus taking into 
account that sufficient material was available for distribution to all 
partners involved, diversity in geographical origin, pre-existing knowledge, 
PrP genotype and results from an initial analysis in a CEA discriminatory 
ELISA-test that recognizes classical scrapie, BSE and atypical scrapie. 
Ultimately 24 isolates were subjected plus one experimental BSE sample 
(Fig. 3). Included was also a DEFRA approved inclusion of samples from 
the United Kingdom where potentially BSE could be involved. 
All above four points have been applied on these 24 samples. Results 
have been accumulated in several deliverables for WP3. Seven rodent 
lines including mice transgenic for goat PrP generated in WP1  (line 
Tg501) were used, and about 10 experimental BSE samples from WP2 and 
a reference goatBSE sample from INRA were used to confirm the BSE 
status if present in the geographical set. Some conclusions were drawn for 
each of these points and have been discussed in the preceding part of this 
report. 
 
Summarizing the degree of achievement in the obtained results with 
respect to the objectives is 100% in nearly all aspects except for the on-
going mouse assays to further validate the potential spread of infectivity 
to milk and the potential risk of milk products for humans. Other issues 
can be considered as being fully achieved. This is illustrated in a time 
scale table (see Table 2). Nevertheless, also these two details of 
objectives 1 and 3 are underway, and come to an end before halfway 
2014. 
 
Table 2: Degree of achievement of objectives initially planned (i.e. activities performed for 
obtaining the intended information). 
 
10 20 30 40 50 60 70 80 90 100
1 Providing data to allow evaluation of human risk associated with BSE passaged in goat a
2 Providing pathogenesis data and biological material from first and second passage BSE in goats
3 Evaluating the possibility of BSE self‐maintenance in goats by maternal/horizontal transmission b
4 Validating and improving our ability to detect and discriminate caprine BSE from goat scrapie 
degree of achievement of efforts 
that were planned to investigate 
the objectives (in %‐age)
a: infection study in humanized (Tg340 129M huPrP) transgenic mice on milk samples ongoing, to be finished at transition 2013‐2014
b: infection study in highly susceptible  (Tg110 bovinized) transgenic mice for milk samples ongoing, to be finished in 2013
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Methodologies and approaches; relation to the 
state-of-the-art 
 
Methods/techniques of special interest to approach scrapie and BSE issues 
and answering questions which these agents might pose to the European 
goat holding and policy makers (with relation to the state-of-the-art 
underlined and in bold): 
1. Creation of transgenic mice carrying goat variant 
PrP alleles to obtain information about the 
susceptibility for scrapie and BSE in goats hosting 
different genetic PrP variants. These are new for 
the TSE scientific world and have significance for 
science in small ruminants field as a means to 
acquire information of susceptibility of small ruminants for TSEs, especially 
BSE.   
2. Design and use of in vitro systems to convert healthy prion protein (PrPC) 
into the disease associated form (PrPSc). Here two new in vitro PrP production 
systems have been generated: a prokaryotic system without application 
of physical forces has been introduced as well as cell lines that supply the 
variant mammalian polymorphic PrPs to study species barrier of TSE 
transmission. 
3. Consolidated protocols for sequencing goat PrP gene especially for the 
coding region as well as for studies in the promotor region; this has allowed 
the analyses on more than 6000 goats in 7 different countries and showed 
that goat PrP is quite polymorphic (>40 PrP variants are now known, 
compared to 29footnote 7 at the start of the project). 
4. A goat nucleus is used and further under development in France where the 
PrP gene is being monitored for further breeding towards healthy 
animals including with respect to TSE agents (unique in the world). 
5. During this project probably the largest scrapie association field studies 
(performed in France) have been added to the already existing studies. 
6. Challenge studies – both intracerebral and oral - with BSE and scrapie have 
been carried out in goats of different PrP genotype to confirm expected TSE 
resistance association as found in field studies:. Such a broad and 
international challenge study in small ruminants is quite unique. 
 
  
 
7. Goat kids were raised in dams when incubating BSE to study maternal 
transmission. 
8. Collected milk from infected dams was separated into cream and whey and 
cellular fractions. Prion material was isolated by immunoprecipitation efforts. 
20 
 
9. Techniques separating milk fractions have been worked out and applied to 
investigate distribution of infectivity between cells, whey, cream and 
whole milk. 
10. An in vitro technique for evaluation of the distribution of prions during cheese 
production has been designed in a prototype procedure. This is a new 
development in TSE research and food safety. 
11. Many tissue samples have been analyzed by microscopic technique of 
immunohistochemistry using the best antibodies available for a broad 
impression of prion spread and prion type in infected goats. 
12. One of the largest geographical collections of natural and experimental 
TSE samples have been created for the aims of the project; this was 
necessary to employ current standards of diagnosis to find out about strain 
variety in a small ruminant species which was not well investigated before in 
goats. 
 
13. EU-approved rapid screening assays for small ruminants have been 
investigated on diagnostic specificity and sensitivity in goats (not 
performed before in such a scale on goat brains). 
14. Several new biochemical prion (PrPres) parameters have been added to 
the already existing diagnostic array of PrPSc characteristics. 
15. Discriminatory biochemical & microscopic techniques focusing on classical 
scrapie, BSE-like and CH1641-like isolates have been applied in one study 
(Figure 6). 
 
 
   
Figure 6: at left a biochemical Western blot picture of different triple band PrPres patterns of 
respectively scrapie (S) & BSE (B) in brain (antibody L42), and at right immunohistochemical 
microscopy of prion positive gut nerve cells (brown means positive; antibody 6C2). Courtesy of 
Jorg Jacobs CVI NL and Kerstin Tauscher FLI GE. 
 
 
16. Transgenic mice carrying bovine, murine, human, porcine, and polymorphic 
goat PrP variants, as well as bank voles and wild type inbred mice have been 
used for different applications: species barrier estimation, human goat 
scrapie- and BSE-susceptibility testing, tissue and milk infectivity 
distribution, titration of infectivity, goat TSE-variability in the field situation. 
This served points 1, 5, 6 and 9 of this paragraph. 
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Impact on research and small ruminants sector 
 
The project will have a number of important outcomes with immediate 
relevance to the “European” problem of BSE in goats: 
1. There was hardly any species barrier observed for transmission of 
goat-BSE. Similar low barrier observations have been obtained with 
sheep BSE (BSE-in-sheep project, FP5 project EU QLK3-CT-2002-
01309, coordinator O. Andréoletti). This suggests that TSE safety 
measures for goats could be comparable to those taken for sheep.  
2. BSE prion distribution and infectivity titres in goat tissues and milk 
have been evaluated. This is yielding useful information on risk 
estimations. It is clear that also outside the brain infectivity in tissues 
like muscle can be present, while for maternal transmission through 
milk still more research has to be done. Anyway, all goat kids from 
positive dams until now have remained negative by microscopy. 
3. The transgenic mouse lines as well as bank voles and conventional RIII 
mice are suitable models to recognize different TSE types in goats; the 
findings can be useful to make choices for the best models for strain 
typing and type identification for BSE, classical scrapie, CH1641 
scrapie and atypical scrapie as well as a separate class of classical 
scrapie, Italian type of classical scrapie. Thus, these models serve as 
improved animal models for detection and discrimination of goat BSE 
from other goat TSEs. 
4. It has been amply possible to check existing methods for their 
performance to diagnose goat scrapies and BSE. New biochemical 
parameters and proper tools (i.c. antibodies) have been defined. The 
methods are suitable at least for expert laboratories, and reagent 
composition will be open to the interested parties. GoatBSE has 
contributed to development of improved and validated (existing) 
diagnostics for goat BSE and scrapie. 
5. Unfortunately, the 171R allele as in ARR-sheep does not occur in 
goats. But there is also good news. Pre-existing information that had 
appeared in the years right before the project had started together 
with new field studies in France from the GoatBSE project have 
confirmed that the genetic variant codon 222K of PrP in 
heterozygous state (222Q/K) is an outstanding allele for breeding 
towards TSE resistance in goats. This result was also confirmed in 
experimental challenges by intracerebral route (until now only for 
scrapie) and the oral route (for 1st and 2nd  passaged BSE). Still, 
studies on intracerebral scrapie and BSE challenges in homozygous 
222K/K goats have to be performed; these have been initiated lately 
at a small scale. These results contribute to propose improved 
guidelines for control of goat TSEs by selective breeding-culling 
strategies. 
6. The large study on a set of different natural goat TSE isolates has 
yielded useful information on the variability of goat scrapie which 
confirms that several phenotypes can often be present in one host. 
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Also, BSE (experimental isolates from different goat PrP genotypes, as 
well as two previously reported goatBSE field isolates from France and 
UK) and atypical scrapie do behave different from all other isolates. 
This work can be considered as a goat TSE reference regarding 
geographical distribution of natural goat TSE strains in Europe. 
7. The above points are useful for scientific reasons, policy makers and 
stakeholders. The data on geographical TSE distribution, the resistance 
related information, the tissue spread of infectivity and a potential 
enhanced risk for humans if BSE-infected goat products would be 
consumed are highly relevant and should keep the society vigilant on 
any emergence of BSE under goats (and possibly sheep and cattle) to 
protect end users. This also means that prevention and inactivation 
tools require attention and potential improvement. In anyway, 
breeding for resistance appears possible. 
8. While the above points described direct practical research output with 
respect to impact on the small ruminants sector, in more generalized 
terms this project has contributed to generation of knowledge in small 
ruminant genetics and pathology research. Dissemination and 
exploitation of results has been promoted and the objectives of the 
project have been adapted to general and strategic lines being: 
o General measures to promote research, technological development 
and innovation:  
 actions in Human Resources: staff dedicated to supporting 
research. 
o Strategic lines and priorities by. 
 development of the reginal territories by promoting respect 
and animal welfare. 
 safety and quality of individual and collective life contributing 
to food safety,  and development of a sustainable, safe and 
healthy food chain. 
 sustainability of social and economic development through 
protecting the economy against the impact of animal 
diseases. 
 its strategic impact by acquiring knowledge about risk factors 
for human exposure to BSE contaminated goat products 
(milk and meat and meat products). 
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DISSEMINATION AND USE OF RESULTS 
Publishable results of the Final plan for using and disseminating the knowledge (see 
format in Appendix 1). 
 
The strategic impact of this project has been to prove sound scientific 
information for use in quantitative risk assessment of human exposure to 
BSE via goat products. The scientific insights gained can contribute to 
promoting food quality and safety through control of goat TSEs within EU 
Member states and regions. This will benefit EU consumer driven concerns 
with regard to food safety and animal welfare and it will assist EU milk and 
meat producers, by reinforcing competitiveness in a global market. 
Objectives and deliverables of this project have provided essential 
information allowing quantification of the risk to humans that BSE 
potentially presents if in goats and their products. In addition, it will 
facilitate the initiation of direct control of TSEs in goats, since currently 
limited control of goat TSEs was based solely on our knowledge of TSE in 
sheep. The cases of caprine BSE found in France and the UK9 have 
indicated that, with respect to TSEs, goats might respond differently than 
sheep, at least after passage in goats BSE is better transmissible to 
several species PrP’s including human PrP. As has been seen with sheep, 
improved genetic and diagnostic tools for controlling goat TSEs should 
lead to significant reductions of scrapie, and perhaps even to control of 
caprine TSEs in EU regions with high TSE outbreaks. Such an outcome 
would greatly reduce both food safety concerns and welfare problems in 
infected animals. Moreover, it would contribute to the sustained 
development of the dairy and meat sector of EU agri-food business by 
decreasing and eventually eliminating the load of TSEs entering the food 
chain. Besides EU interests, this project is serving a world with intentions 
to reduce prion risks for human consumers and animals.  
 
The GoatBSE consortium’s plan for using and disseminating the knowledge 
at the end of the project, has been to provide a complete picture of the 
activities undertaken and most importantly will provide information on the 
future route to full use (exploitation or use in further research) and 
dissemination of the knowledge. 
 
Section 1 - Exploitable knowledge and its Use 
The contractors have not developed any special exploitable knowledge 
having a potential for industrial or commercial application in research 
activities or for developing, creating or marketing a product or process or 
for creating or providing a service. The project was intended to yield 
scientific progress in prion field, and information for safety and risk 
assessment towards humans and animals with respect to BSE in goats. 
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Section 2 – Dissemination of knowledge. 
 
 
 
 
Final plan for using and disseminating the knowledge 
 
see table: “Final plan for using and disseminating 
the knowledge”  
after page 27. 
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Section 3 - Publishable results 
GoatBSE - being a typical scientific project with eye mark on human and 
animal risk for BSE transmission – has been publishing mainly in scientific 
peer review articles, which are displayed in the previous section 
“Dissemination of knowledge” and “Impact on research and small 
ruminants sector”. No exploitable results are opportune in this project. 
The GoatBSE project is rather a scientific contribution with significant 
practical results for goat farming; the only material contribution are 
potentially transgenic mouse lines which have been created to express 
variant goat PrP alleles; the publication of the production and use of these 
lines can be expected within two years from now by partner 4 via peer 
reviewed scientific papers(INIA, Madrid). We have produced a 
stakeholders publication in International Innovation entitled Eradicating 
BSE in goats (see green pages at the end of this report). 
 
Pilot activities to TSE-resistance breeding have been initiated in a new EU-
supported follow-up study in the EMIDA ERA net under the acronym GOAT 
TSE FREE. 
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ABBREVIATIONS 
 
BSE bovine spongiform encephalopathy 
CNS central nervous system (brain and spinal cord) 
DOW Description of work document; in fact the official technical 
description of the whole project. 
dpi days post infection 
ENS enteric nervous system (nerve cells in the gut) 
Ggl ganglion; a junction outside the central nervous system where 
nervous cells have their connections 
IHC immunohistochemistry, a microscopic technique that uses PrPSc 
detection with PrP specific antibodies 
IPP ileal Peyer’s patch; a lymph node in the ileum 
LRS lympho-reticular system (such as lymph nodes and spleen) 
mpc months post challenge 
mpi months post infection 
PK proteinase K, a powerful microbial protease removing all PrPC but 
leaving PrPSc partially unaffected 
PRNP gene coding for PrP 
PrP prion protein, in normal form a cellular protein (PrPC) considered 
to be the target and potential agent in TSEs or prion diseases 
PrPDis PrP deposits observed when performing IHC on TSE diseased 
tissue 
PrPres the PK-resistant part of PrPSc as seen with Wbl and ELISA 
PrPSc the disease associated form of PrP originating from a change in 
structure and aggregation of PrP. 
Tg transgenic, which means that the PRNP gene has been replaced 
by a foreign PrP with DNA techniques 
TSE transmissible spongiform encephalopathy 
Wbl Western-blotting, a biochemical technique that uses degradation 
of proteins with proteinase K, subsequent separation of the digest 
followed by detection of the resistant PrPSc with PrP-specific 
antibodies 
wt wild type for the PrP sequence; in the DOW v41 mentioned as 
I142R211Q222. On position 154 these animals are also wild type with 
a R154 
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DISSEMINATING THE KNOWLEDGE 
 
 
Results of dissemination plan 
 
See pages  28-32 
Planned/actual
Dates 
5-10-2007 Flyer: General project information flyer. Research & Higher education EU EU P1
6-2008
Publication: GoatBSE, project showcase. In Emerging Epidemics 
Research (EU funded projects) 2002-2008 by the EC-European 
Research Area. Pages 74-75. 
Policy & Research EU EU P1
Oct 8, 2008 Information: Animal TSEs workshop in Prion2011 at Madrid Policy & Research world 120 P1
nov-08 Publication:  Several contributions (pages 1-2 and 8-9) in the NeuroPrion Prion2008 special issue newsletter. Research & Higher education world world P1 P4
3-2009 Information : EFSA Scientific Opinion Genetic TSE resistance in goats March 2009 Policy & Research EU world P1, P2, P7, P8
23 September, 
2009
Information: Animal TSEs workshop in Prion2009 at Porto Carras, 
Greece Research, policy makers 100 world P9
7-2009 Information : State-of-the-art review goat TSEs Public and Research world world P1, P2, P3, P4, P5, P6, P7, P8, P9
during 2010-2012
Information: Several items like literature list, workshop 
announcements, announcements on new papers, stakeholders lists. 
see website: www.goatbse.eu
Public and Research and 
Stakeholders world world
P1, P2, P3, P4, P5, 
P6, P7, P8, P9
during 2011 Information: animal TSEs workshop in Prion2011 at Montreal Research world 120 P1, P8
9 May 2012 Information : Animal TSEs workshop in Prion2012 at Amsterdam; May 9th 2012 Research world 200 P1, P8
2012
Publication: Eradicating BSE in goats: in International Innovation. 
EuroFocus Issue February 2012 pages 100-102.  (SEE AT END OF 
THIS PLAN)
Stakeholders: policymakers, 
goat sector, EU-officers, 
national agricultural offices.
Europe Europe P1
Project web-site 
activities
dec-2006 Private consortium web-portal operational Research consortium + EC <30 P1
sep-2007 First version public website operational www.goatBSE.eu Research & Higher education Worldwide - P1
sep-2008 Full public website operational www.goatBSE.eu Research & Higher education Worldwide - P1
oct/nov-2008 Several meeting announcements (www.goatBSE.eu) Research & Higher education Worldwide - P1
19-11-2008 Executive summary of year 1 posted (www.goatBSE.eu) Research & Higher education Worldwide - P1
dec-09 Post Executive summary year 2 (www.goatBSE.eu) Research & Higher education Worldwide - P1
Apr & Oct 2009 Announcements and report on workshop on Animal TSEs, Porto Carras, Greece (22Sep2009) Research & Higher education Worldwide 100 P1
9-nov-09 Workshop: Goat genetics and TSEs Research specialists United Kingdom 10 P3=P12
cont 2010 Newsflashes on website (www.goatBSE.eu) Research & Higher education Worldwide - P1
cont 2010 Some popular articles (www.goatBSE.eu) General public & Higher education Worldwide - P1 / all
cont 2010 Native translations of popular and review (www.goatBSE.eu) General public & Higher education Worldwide - P1 / all
2010 Improve stakeholder section General public & Higher education Worldwide - P1 / all
2010 Executive summary year 3 (www.goatBSE.eu) Research & Higher education Worldwide - P1 / all
2011 Executive summary year 4 (www.goatBSE.eu) Research & Higher education Worldwide - P1 / all
2011 Goat TSEs literature list Research & Higher education Worldwide - P1 / all
2012 Executive summary year 5 (www.goatBSE.eu) Research & Higher education Worldwide - P1 / all
2013 Executive summary year 6 (www.goatBSE.eu) Research & Higher education Worldwide - P1 / all
2013 Final report GoatBSE project for public Research & Higher education Worldwide - P1 / all
2008 P7 P8
2008 P7 P3 P1
2008 P2
2008 P10, P2
2008 P10, P2, P4
2008 P10
2008 P10, P4, P2
2009 P8 P7 P9 P5 P1 P2 P12/3 P6
Dissemination of information to general public
Acutis PL, Colussi S, Santagada G, Laurenza C, Maniaci MG, Riina MV, Peletto S, Goldmann W, Bossers A, Caramelli M, Cristoferi I, 
Maione S, Sacchi P, Rasero R. Genetic variability of the PRNP gene in goat breeds from Northern and Southern Italy.  J Appl Microbiol. 
(2008), 104(6):1782-9.
Colussi S, Vaccari G, Maurella C, Bona C, Lorenzetti R, Troiano P, Casalinuovo F, Di Sarno A, Maniaci MG, Zuccon F, Nonno R, 
Casalone C, Mazza M, Ru G, Caramelli M, Agrimi U, Acutis PL. Histidine at codon 154 of the prion protein gene is a risk factor for Nor98 
scrapie in goats.  J Gen Virol. 2008 Dec;89(Pt 12):3173-6
Peer reviewed publications (35 until now, more to come)
Gabriele Vaccari, Cynthia Panagiotidis, Cristina Acin, Pierluigi Acutis, Alex Bossers, Jan Langeveld, Theodoros Sklaviadis Francis 
Barillet, Olivier Andréoletti, Jim Foster and Wilfred Goldmann. State-of-the-art review of goat TSE in the European Union, with special 
emphasis on PRNP genetics and epidemiology. Veterinary Research. Vet. Res. 40(2009)48
Simon S, Nugier J, Morel N, Boutal H, Créminon C, Benestad SL, Andréoletti O, Lantier F, Bilheude JM, Feyssaguet M, Biacabe AG, 
Baron T, Grassi J. Rapid typing of transmissible spongiform encephalopathy strains with differential ELISA.  Emerg Infect Dis. 2008 
Apr;14(4):608-16. 
Grassi J, Maillet S, Simon S, Morel N.  Progress and limits of TSE diagnostic tools. Vet Res. 2008 Jul-Aug;39(4):33
18284910
Maluquer de Motes C, Grassi J, Simon S, Herva ME, Torres JM, Pumarola M, Girones R. Excretion of BSE and scrapie prions in stools 
from murine models. Vet  icrobiol. 2008 Sep 18;131(1-2):205-11.
Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbière F, Cassard H, Costes P, Bergonier D, Weisbecker JL, Moldal 
T, Simmons H, Lantier F, Feraudet-Tarisse C, Morel N, Schelcher F, Grassi J, Andréoletti O.  PLoS Pathog. 2008 Dec;4(12):e1000238. 
Prions in milk from ewes incubating natural scrapie.
 PLoS Pathog. 2008 Dec;4(12):e1000238.
goatBSE (EU contract 36353) Final plan for using and disseminating the knowledge
Type
Dissemination of information
1 December 2006 - 30 November 2012
Complete project period Dec2006-Nov2012
Type of audience Countries addressed Size audience
Partners involved/ 
responsible
Barillet F., Caillat H., Amigues Y., Babilliot J.M., Faugeras R., Bouvier F., Lacroux C., Schelcher F., Chartier C., Andreoletti O., Perrin-
Chauvineau C., Corbière F. 2008. Tremblante caprine : polymorphismes du gène PRNP de l’hôte et résistance à l’infection en races Alpine et 
Saanen. 15èmes Rencontres Recherches Ruminants, Paris, France, 3-4 décembre 2008, 415-418
55
2009 P2
2009 P12
2009 P5
2009 P5, P7
2009 P12
2009 P9
2010 P1, AHVLA
2010 P1, P5, P6, P7, AHVLA
2010 P1, CODA
2010 P8, P1
2010 P2
2010  P4, P2, P1
2010 P5
2010 P5
2010 P5
2010 P5
2010 P5
2010 P6
2011 P9, P1
2011 P12, P1, AHVLA
2011 P1, AHVLA
2011 P4, P2, P1
2012 P1, P2a, AHVLA, ANSES, NIAH
2012 P7
2012 P1, P2a, AHVLA, ANSES, NIAH
2012 P7
2013 P2a,c
7-okt-08 Workshop:  Workshop on TSEs in Goats, Cervids and Sheep. Prior to the international Prion2008 conference. Research & Higher education World-wide 180 P1
F. Barillet, C. Lacroux, S. Lugan, H. Caillat, Y. Amigues, J.M. Babilliot, R. Faugeras, C. Chartier, C. Perrin-Chauvineau, F. Schelcher, O. 
Andreoletti, F. Corbière, 2010. Protective effect of the I142R154R211K222S240 PrP allele against classical scrapie in French Alpine and 
Saanen goat breeds, 9th word congress on genetics applied to livestock production, Leipzig, Germany, August 1-6, 2010, CD-ROM, pp4-155
Danielle Padilla,  Vincent Béringue, Juan Carlos Espinosa, Olivier Andreoletti, Emilie Jaumain, Fabienne Reine, Laetitia Herzog, 
Alfonso Gutierrez, Belen Pintado,  Hubert Laude and Juan Maria Torres. Sheep and Goat BSE Propagate More Efficiently than Cattle BSE 
in Human PrP Transgenic Mice. PLoS Pathogens (in press)
Monleón E, Garza Ma, Sarasa R, Alvarez-Rodriguez J, Bolea R, Monzón M, Vargas  Ma, Badiola JJ, Acín C. An assessment of the 
efficiency of PrPsc detection in rectal mucosa and third-eyelid biopsies from animals infected with scrapie. Vet Microbiol. 6 (2010).
Bolea R, Vidal E, Marín B, Márquez M, Vargas A, Pumarola M, Badiola JJ. Rapid chromatographic immunoassay study of brain PrPsc 
distribution in classical scrapie. J Vet Diagn Invest. Jan;22(1):82-5. (2010).
Bertolini S, Maniaci M-G, Colussi S, Modesto P, Biolatti C, Bertuzzi S, Caramelli M, Maurella C, Acutis P-L. Association of an indel 
polymorphism in the 3’UTR of the caprine SPRN gene with scrapie positivity in the central nervous system. (2012) J Gen Virol 93, 1620-1623.
Jacobs JG, Sauer M, van Keulen LJM, Tang Y, Bossers A, and Langeveld JPM. 2011. Differentiation of ruminant TSE isolate types, 
including BSE and CH1641 scrapie. J Gen Virol. 92: 222 – 232.
Goldmann W, Ryan K, Stewart P, Parnham D, Xicohtencatl R, Fernandez N,  Saunders G, Windl O, González L, Bossers A, Foster J 
(2011) Caprine prion gene polymorphisms are associated with decreased scrapie susceptibility in goat herds in the United Kingdom. Vet Res 
42, 110.
Bertolini S, Maniaci M-G, Colussi S, Modesto P, Biolatti C, Bertuzzi S, Caramelli M, Maurella C, Acutis P-L. Association of an indel 
polymorphism in the 3’UTR of the caprine SPRN gene with scrapie positivity in the central nervous system. (2012) J Gen Virol 93, 1620-1623.
Tang Y, Gielbert A, Jacobs JG, Baron T, Andreoletti O, Yokoyama T, Langeveld JP, Sauer MJ.  2012. All major prion types recognised by 
a multiplex immunofluorometric assay for disease screening and confirmation in sheep. J Immunol Methods 380:30–39.
Bouzalas, I. G., Lortscher, F., Dovas, C. I., Oevermann, A., Langeveld, J. P., Papanastassopoulou, M., Papadopoulos, O.,  Zurbriggen, 
A. & Seuberlich, T. A Distinct Proteinase K Resistant Prion Protein Fragment in Goats with No Signs of Disease in a Classical Scrapie 
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2010 Scientific Opinion on BSE/TSE infectivity in small ruminant tissues EFSA Panel on Biological Hazards (BIOHAZ). EFSA Journal 2010;8(11):1875 Expert activities Europe P1, P2, P6, P7
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Dr Jan Langeveld, acting coordinator of the GoatBSE consortium, and former coordinator Dr Alex Bossers 
discuss their plans for breeding goats which are insensitive to the infectious agents responsible for past 
epidemics of ‘mad cow disease’, namely the bovine spongiform encephalopathy agent and similar prions
Could you outline the primary aims of your 
research?
Our consortium aims to generate data for 
human bovine spongiform encephalopathy 
(BSE) risk estimations related to the 
consumption of goat products. We will obtain 
an EU-wide insight into the characteristics 
and control of transmissible spongiform 
encephalopathies (TSEs, a generic name for 
prion disease like BSE and scrapie) in goats. Our 
fi eld research collects national and regional 
information on TSE variants and the genetic 
background of susceptibility in animals from 
the main goat producing countries in Europe. 
The laboratory research will estimate the risk 
of disease transmissibility, especially between 
goats and humans. 
Why is the fi eld of TSEs so signifi cant?
The BSE epidemic that started in the UK in the 
1980s and subsequently spread through Europe 
provides the impetus for our research. The source 
of the epidemic remains unknown, but the most 
plausible explanations are either small ruminants 
such as goats that are known targets of this 
disease, or infected cattle that went unnoticed 
because infections were rare or because clinical 
signs appear late in the animals’ lifespan.
The epidemic developed following the feeding 
of insuffi ciently inactivated ruminant derived 
meat and bone meal rations to cattle. TSEs, and 
especially the BSE 
crisis, have shown 
in a very costly 
way that certain 
infectious diseases 
are behaving as new 
agents, are diffi cult 
to pasteurise and 
have unpredictable 
epizootic and 
zoonotic behaviour 
(properties which 
mean animal 
diseases can affect 
other animal 
species including 
humans). BSE 
infected several hundred thousand cattle, and 
also a few hundred people suffered from the 
human variant that causes Creutzfeldt-Jakob 
disease. The disease in humans and animals is 
still incurable and untreatable, and involves 
progressive brain degeneration.
Eradicating TSEs in goats means no possibility 
of hazardous transmissions through the animal 
production sector or from animals to society.
Can you provide a summary of some of the 
techniques you are using in the project?
This approach combines many techniques: 
we are testing healthy and infected goats 
with prion protein (PrP) gene polymorphisms 
for their genetic susceptibility to infection, 
producing transgenic mice with goat PrP genes 
highly susceptible to the disease; in vitro PrP 
misfolding studies using specially designed 
PrP variants; and testing goats with different 
PrP polymorphisms for resistance to BSE and 
scrapie infection. 
We are also analysing caprine TSE strain 
variations in seven EU countries (Greece, 
Cyprus, Italy, Spain, France, The Netherlands 
and the UK), testing the infectivity levels of 
TSE-infected goat tissues using caprinised and 
humanised transgenic mice, and testing for 
the potential survival of TSE infectivity in the 
cheesemaking process.
Why is it important to study samples from a 
large geographical range?
The PrP polymorphisms conferring resistance to 
TSEs are rare, so sampling many animals with 
a broad range of genetic diversity is important 
– data from many geographical locations 
and breeds of production goat are desired. 
Furthermore, different TSE strains are expected 
to occur at various geographical locations and 
these might have different PrP-based genetic 
resistance profi les.
What are some achievements of the project 
so far?
A very promising resistance allele has been 
detected in goats in Cyprus, though in most 
countries of Europe this is absent. This is already 
being used in a resistance breeding programme 
in Cypriot goats as European Food Safety 
Authority (EFSA) approved emergency action 
due to the very high scrapie incidence there. 
However, more experimental work is needed 
to confi rm the effectiveness of this strategy. 
Another allele found at higher frequencies in 
the other EU countries has yet to be confi rmed 
as a resistance allele, though we have a 
better experimental basis to start a breeding 
programme with this than we do with the allele 
identifi ed in Cyprus.
Who will benefi t from the project? 
The European Food Safety Authority (EFSA) 
advocates our work for the promotion of safe 
food for consumption in the EU. Also, this work 
is of particular concern for producers of goat 
milk: their products are enjoying an increased 
appreciation throughout Europe. 
Goat TSEs are a serious issue, since 
identifying one infected animal means 
a whole herd must be culled, which is 
unethical, economically diffi cult for farmers, 
and goes against public opinion if there 
are alternatives that could be developed. 
Although the BSE problem has subsided 
in cattle, goat TSEs still have a continuing 
impact on farmers who raise these animals.
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Avoiding the cull
BSE, the prions responsible for epidemics of ‘mad cow disease’, have recently been identifi ed in goats. In response, 
the GoatBSE consortium is examining the risk posed to humans, and hopes to breed disease resistant animals
THE BOVINE SPONGIFORM encephalopathy 
(BSE) outbreaks in the 1980s led to the culling 
of several million cattle in the UK and Europe, 
and the infectious agents responsible – proteins 
called prions – grew in notoriety by crossing 
the species barrier to infect humans, causing 
around 200 cases of the fatal neurodegenerative 
condition Creutzfeldt-Jakob disease.
The tolls of the BSE epidemics helped to spur 
on the formation of the European Food Safety 
Agency (EFSA) in 2002, which began actively 
surveying livestock other than cattle for various 
forms of BSE related transmissible spongiform 
encephalopathies (TSEs) in order to safeguard 
humans from new routes of infection through 
the consumption of small ruminants (sheep 
and goats). 
In 2005, concerns about ulterior risks of TSEs 
grew when the EFSA reported the fi rst case 
of a BSE infection in goats. In response to 
this, researchers convened to structure and 
stimulate goat TSE studies; this was initially 
executed under the EU-funded FP6 Neuroprion 
network. Subsequently, the GoatBSE project 
was commissioned to investigate the control 
of TSEs in goats and to estimate the risk of 
transmissibility of the agents, both between 
members of a herd and between goats and 
humans. Previous efforts made to avoid future 
mass culls of infected livestock successfully led, 
in several EU regions, to the breeding of sheep 
that appear resistant to TSEs, and the European 
Commission has pushed for a repeat of such a 
breeding programme in goats.  
However, as Dr Jan Langeveld – an acting 
coordinator of the GoatBSE consortium – 
explains, TSEs and BSE in goats have had a long 
history without much scrutiny: “For centuries, 
TSEs have been known as scrapie in sheep 
and goats but it only became apparent that 
the disease was transmissible in the 1930s,” 
he outlines. “TSEs are commonly recognised 
to cause three main forms of disease in small 
ruminants: classical scrapie, BSE, and atypical 
scrapie. BSE has recently been found in two goats 
to date (one in France and another in the U.K.), 
and while no cases have been reported in sheep 
thus far, both are susceptible to infection when 
fed brain tissue from infected cattle.”
Comprising of a consortium of 10 institutions in 
seven EU Member States and funded by the EU’s 
FP6 Food Programme and national governments, 
GoatBSE is now addressing the paucity of 
knowledge surrounding TSE infections in goats. 
An up-to-date website is available to inform 
scientists and stakeholders (www.goatTSE.eu).
 TISSUE INFECTIVITY
The project has already made headway on several 
fronts. One of the primary aims of GoatBSE is 
the clinical investigation of the diseases in goats 
which are inoculated with – or orally exposed 
to – prions. The team is specifi cally looking at 
the infectivity distribution of BSE and TSEs in 
cells involved in the central nervous system or 
peripheral nervous and lymphatic tissues (which 
prions target), as well as tissues which may be 
more relevant to human consumption such as 
muscle, intestines and milk-based products. 
Screening tissues for the presence of infection, 
and for the presence of the malfolded protein 
PrPSc which is associated with disease status 
diagnostics, is conducted by testing in highly 
susceptible transgenic mice. 
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So far, clinical disease has been observed in 
brain tissue following the inoculation of goats 
with varying levels of natural resistance to TSEs 
offered by different prion protein gene (PrP) 
polymorphisms (gene characteristics which vary 
in populations). Some goats have shown BSE 
infection status in enteric nerve cells within a 
year of oral passage of the prion. 
Further work to quantify the risk of transmissibility 
of diseases from animal to animal, and to humans 
via the consumption of infected meat or milk, is 
underway. “Concerns about milk consumption 
are warranted because, in sheep, milk from 
infected ewes can be involved in the transmission 
of TSEs to their lambs,” Langeveld points out. 
More understanding of the risks involved in 
consuming goat products will help to promote 
food safety in the EU Member States. 
Understanding disease status also depends on 
surveying goat populations for different strains 
of TSEs across Europe. To do so, the GoatBSE 
consortium conducted a large study on the 
geographical distribution of the diseases in major 
goat-producing regions of seven EU Member 
States (Greece, Cyprus, Italy, Spain, France, 
The Netherlands and the UK). Biochemical 
analysis and determination of biological 
transmission characteristics in susceptible 
rodent models is ongoing, with more samples 
currently being collected from institutions 
outside of the consortium. Such efforts should 
serve to characterise the breadth of variation in 
strains of prions which infect goats locally and 
internationally. 
BREEDING RESISTANCE
Another line of enquiry for the team is to 
identify and determine the infl uence of genetic 
polymorphisms in PrP on the susceptibility of 
goats to infection by BSE and TSEs. This has 
been carried out by comparing the genes of 
scrapie – infected animals with those of their 
uninfected peers in the same herds. Initially, 
this involved analysing infected fi eld herds 
where susceptibility appeared dependent on PrP 
polymorphisms. Subsequently, the team used 
various TSE inoculations to infect a series of 
goats with differing PrP polymorphisms, and also 
tested the transmissibility of infection between 
goats with different genetic variants using 
caprinised transgenic mice or in vitro models. 
Useful PrP polymorphisms may be rare among 
goats, and the frequency of different alleles can 
vary across regional and/or national populations, 
so the project screened and genotyped goats for 
variation in the PrP gene in each of the seven 
countries involved.
The efforts have led to the identifi cation of 
possible resistance polymorphisms which are 
present at low frequencies throughout the 
various European goat populations. Evidence 
confi rms that the 146 mutation in the PrP 
gene offers a strong degree of resistance to TSE 
infection, but currently this is a very rare allele 
in goat populations outside of Cyprus. The 222 
mutation is present at higher frequencies than 
146 in other EU countries, and there is a stronger 
basis for it being used in breeding resistance, but 
work to confi rm the level of resistance that it 
confers is ongoing. Further in vitro studies of 
prion protein malfolding in animals with the 
222 mutation will help with this. 
When suitable polymorphisms are found 
to have meaningful benefi ts for boosting 
resistance to prions in the animals, the next 
stage is to use breeding programmes to 
increase the frequency of these. Langeveld 
states the potential of such programmes: 
“There are very promising results from goat 
challenge experiments (with scrapie and BSE) 
that suggest breeding resistance to TSEs is 
possible. At this stage, little action has been 
undertaken to use breeding but it is subject for 
new work and pilot fi eld studies”.
IMPLICATIONS OF GOATBSE
All of these insights will contribute to a safer 
and more robust market for goat products in 
the EU. Though concerns about BSE epidemics 
in cattle have reduced recently, the risks of prion 
infections posed by the consumption of goat 
meat and milk have not been quantifi ed. Some 
regions of the EU (such as Cyprus) currently 
have a high incidence of scrapie in goat herds, 
at a time when Europeans are increasingly 
consuming goat meat, milk and milk-derived 
products. These factors, along with new 
concerns about the rise of caprine BSE cases, 
suggest that assessing the transmissibility of 
these diseases from goats to humans is rightly 
deemed a priority for minimising health risks to 
consumers.
The developments made by GoatBSE will also 
facilitate the control of TSEs in goats. Scrapie 
and related infections of single animals currently 
necessitate the culling of entire herds, the results 
of which are extremely wasteful, evoke strong 
public outcry and severely damage the fi nancial 
prospects of farmers. By reining in the impact 
of TSEs on goat populations through breeding 
programmes used to raise prion resistant 
animals, mass culls can be avoided. Thanks to 
GoatBSE, both consumers and producers will 
eventually benefi t from healthier herds.
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